Exact Mass: 562.2791
Exact Mass Matches: 562.2791
Found 500 metabolites which its exact mass value is equals to given mass value 562.2791
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Protoporphyrin IX
Protoporphyrins are tetrapyrroles containing 4 methyl, 2 propionic, and 2 vinyl side chains. Protoporphyrin is produced by oxidation of the methylene bridge of protoporphyrinogen. Protoporphyrin IX is the only naturally occurring isomer; it is an intermediate in heme biosynthesis, combining with ferrous iron to form protoheme IX, the heme prosthetic group of hemoglobin. Protoporphyrin IX is created by the enzyme protoporphyrinogen oxidase. The enzyme ferrochelatase converts it into heme. Protoporphyrin IX naturally occurs in small amounts in feces. Protoporphyrin IX is also responsible for the brown pigment (ooporphyrin) of birds eggs. Protoporphyrin IX is used as a branch point in the biosynthetic pathway leading to heme (by insertion of iron) and chlorophylls (by insertion of Mg and further side-chain transformation). Protoporphyrin IX can be used to treat liver disorders, mainly as the sodium salt. Under certain conditions, protoporphyrin IX can act as a neurotoxin, a phototoxin, and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. A phototoxin causes cell damage upon exposure to light. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of porphyrins are associated with porphyrias such as porphyria variegate, acute intermittent porphyria, and hereditary coproporphyria (HCP). In particular, it is accumulated and excreted excessively in the feces in acute intermittent porphyria, protoporphyria, and variegate porphyria. There are several types of porphyrias (most are inherited). Hepatic porphyrias are characterized by acute neurological attacks (seizures, psychosis, extreme back and abdominal pain, and an acute polyneuropathy), while the erythropoietic forms present with skin problems (usually a light-sensitive blistering rash and increased hair growth). The neurotoxicity of porphyrins may be due to their selective interactions with tubulin, which disrupt microtubule formation and cause neural malformations (PMID: 3441503). obtained by demetallation of Haemin, occurs in small amounts in faeces. Brown pigment (Ooporphyrin) of birds eggs. Isolated from Atolla wyvillei (CCD). Protoporphyrin is found in red beetroot. D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents COVID info from COVID-19 Disease Map C1420 - Photosensitizing Agent D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Protoporphyrin IX is the final intermediate in the heme biosynthetic pathway. Protoporphyrin IX is the final intermediate in the heme biosynthetic pathway.
19-Hydroxycinnzeylanol 19-glucoside
19-Hydroxycinnzeylanol 19-glucoside is found in herbs and spices. 19-Hydroxycinnzeylanol 19-glucoside is a constituent of Cinnamomum cassia (Chinese cinnamon). Constituent of Cinnamomum cassia (Chinese cinnamon) [CCD]. 19-Hydroxycinnzeylanol 19-glucoside is found in herbs and spices.
Lactandrate
Caseanigrescen C
A diterpenoid of the clerodane group isolated from the leaves and flowers of Casearia nigrescens. It exhibits cytotoxicity against A2780 human ovarian cancer cell line. Caseanigrescen C is a diterpenoid of the clerodane group isolated from the leaves and flowers of Casearia nigrescens. It exhibits cytotoxicity against A2780 human ovarian cancer cell line. It has a role as a metabolite and an antineoplastic agent. It is an acetate ester, a butyrate ester, a cyclic ether, a diterpenoid, an organic heterotricyclic compound and a secondary alcohol.
(1R,3aR,3bS,4aR,6S,7S,7aR,8R,8aR,9aR)-1,4a,8-tris(acetyloxy)-2,2,3b,6,8a-pentamethyl-4,9-dioxo-tetradecahydro-1H-cyclopenta[a]s-indacen-7-yl butanoate
15,17-di-O-acetyl-3-O-cinnamoyl-17-hydroxyjolkinol
3-O-beta-D-Rhamnopyranoside-3,8,12,14-Tetrahydroxybufa-4,20,22-trienolide
3-O-beta-D-Glucopyranoside-3,14,16-Trohydroxybufa-4,20,22-trienolide
(24E)-5alpha-cholest-24-ene-3beta,4beta,6alpha,8,14,15alpha,26-heptaol 15-O-sulfate
4,5-dihydrogaldamycin|4,5-Dihydrogeldanamycin|geldanamycin
(1S,3aR,5S,6R,7S,7aR)-1-(1-acetoxyethyl)octahydro-6-[(2-methylbutanoyl)oxy]-4-methylidene-7-[(2S)-2-methyloxyran-2-yl]-2-oxo-1H-inden-5-yl (2E)-4-acetoxy-3-methylpent-2-enoate
2-heptyl-6-methoxy-1,4-hydroquinone-1,4-di-O-beta-D-glucopyranoside
(22-27)-hexanorcucurbitacin I 2-O-beta-D-glucopyranoside|2,16-dihydroxy-22,23,24,25,26,27-hexanorcucurbit-5-ene-11,20-dione 2-O-beta-glucopyranoside|2-O-beta-D-glucopyranosyl-(22-27)-hexanorcucurbitacin I|khekadaengoside K
(1alpha,2alpha,3beta,5alpha,6beta)-2,5,8-tris(angeloyloxy)-10,11-epoxy-1,3-dihydroxybisabol-7(14)-en-4-one|(2Z,2Z)-2-methylbut-2-enoic acid rel-(1R,2S,4S,5R,6R)-2-{3-(3,3-dimethyloxxiranyl)-1-methylene-2-{[(2Z)-2-methyl-1-oxobut-2-enyl]oxy}propyl}-2,6-dihydroxy-2-methyl-3-oxocyclohexane-1,4-diyl ester|3alpha,6alpha,9-tris(angeloyloxy)-2alpha,4beta-dihydroxy-7,11-epoxybisabol-10(15)-en-5-one
(6S)-2-trans-2,6-dimethyl-6-<3-O-(beta-D-glucopyranosyl)-4-O-(2-methylbutyroyl)-alpha-L-arabinopyranosyloxy>-2,7-octadienoic acid|(6S)-2-trans-2,6-dimethyl-6-[3-O-(beta-D-glucopyranosyl)-4-O-(2-methylbutyroyl)-alpha-L-arabinopyranosyloxy]-2,7-octadienoic acid
6alpha-19-diacetoxy-1beta-tigloyloxy-4alpha-18-epoxyneo-clerod-12-en-15-oic acid methylester-16-aldehyde|ajugacumbin J
(20S)-18,20-epoxystrophanthidin-4,6-dideoxy-2,3-methylenedioxy-beta-D-allopyranoside|reevesioside G
3-O-beta-D-glucopyranosylalbicanol-11-O-beta-D-glucopyranoside
6alpha--7beta-<3-methylvaleryloxy>-6,7-desacyloxy-abrotanifolon-13-saeuremethylester
methyl-ent-7alpha,15alpha-diacetoxy-1alpha-(2-methyl-2,3-epoxybutyryloxy)-9alpha-hydroxykaur-16-en-19-oate|methyl-ent-7alpha,15alpha-diacetoxy-1alpha-<2-methyl-2,3-epoxybutyryloxy>-9alpha-hydroxykaur-16-en-19-oate
(1alpha,2alpha,3beta,5alpha,6beta)-1,5,8-tris(angeloyloxy)-10,11-epoxy-2,3-dihydroxybisabol-7(14)-en-4-one|(2Z,2Z)-2-methylbut-2-enoic acid rel-(1R,2S,3S,4S,5R)-2-{3-(3,3-dimethyloxxiranyl)-1-methylene-2-{[(2Z)-2-methyl-1-oxobut-2-enyl]oxy}propyl}-4,5-dihydroxy-5-methyl-6-oxocyclohexane-1,3-diyl ester
(20S,22R)-12alpha-acetoxy-2alpha,3alpha,6alpha,7alpha-diepoxy-1alpha,5alpha,16alpha,27-tetrahydroxywith-24-enolide|plantagiolide F
12-tigloyl-13-(2-methylbutanoyl)-6,7-epoxy-4,5,9,12,13,20-hexahydroxy-1-tigliaen-3-one|EBI-46
protoporphyrin IX
Protoporphyrin IX is the final intermediate in the heme biosynthetic pathway. Protoporphyrin IX is the final intermediate in the heme biosynthetic pathway.
C30H42O10_Butanoic acid, (1R,3aR,3bS,4aR,6S,7S,7aR,8R,8aR,9aR)-1,4a,8-tris(acetyloxy)tetradecahydro-2,2,3b,6,8a-pentamethyl-4,9-dioxo-1H-cyclopent[a]-s-indacen-7-yl ester
(1R,3aR,3bS,4aR,6S,7S,7aR,8R,8aR,9aR)-1,4a,8-tris(acetyloxy)-2,2,3b,6,8a-pentamethyl-4,9-dioxo-tetradecahydro-1H-cyclopenta[a]s-indacen-7-yl butanoate_major
Ala Met Arg Trp
Ala Met Trp Arg
Ala Arg Met Trp
Ala Arg Trp Met
Ala Trp Met Arg
Ala Trp Arg Met
Cys Glu Arg Arg
Cys Arg Glu Arg
Cys Arg Arg Glu
Cys Arg Val Trp
Cys Arg Trp Val
Cys Val Arg Trp
Cys Val Trp Arg
Cys Trp Arg Val
Cys Trp Val Arg
Glu Cys Arg Arg
Glu Lys Met Arg
Glu Lys Arg Met
Glu Lys Thr Trp
Glu Lys Trp Thr
Glu Met Lys Arg
Glu Met Arg Lys
Glu Arg Cys Arg
Glu Arg Lys Met
Glu Arg Met Lys
Glu Arg Arg Cys
Glu Thr Lys Trp
Glu Thr Trp Lys
Glu Trp Lys Thr
Glu Trp Thr Lys
Phe Phe His Ile
Phe Phe His Leu
Phe Phe Ile His
Phe Phe Leu His
Phe His Phe Ile
Phe His Phe Leu
Phe His Ile Phe
Phe His Leu Phe
Phe Ile Phe His
Phe Ile His Phe
Phe Leu Phe His
Phe Leu His Phe
His Phe Phe Ile
His Phe Phe Leu
His Phe Ile Phe
His Phe Leu Phe
His His Asn Arg
His His Arg Asn
His Ile Phe Phe
His Ile Met Tyr
His Ile Tyr Met
His Leu Phe Phe
His Leu Met Tyr
His Leu Tyr Met
His Met Ile Tyr
His Met Leu Tyr
His Met Tyr Ile
His Met Tyr Leu
His Asn His Arg
His Asn Arg His
His Arg His Asn
His Arg Asn His
His Tyr Ile Met
His Tyr Leu Met
His Tyr Met Ile
His Tyr Met Leu
Ile Phe Phe His
Ile Phe His Phe
Ile His Phe Phe
Ile His Met Tyr
Ile His Tyr Met
Ile Met His Tyr
Ile Met Asn Trp
Ile Met Trp Asn
Ile Met Tyr His
Ile Asn Met Trp
Ile Asn Trp Met
Ile Trp Met Asn
Lys Glu Met Arg
Lys Glu Arg Met
Lys Glu Thr Trp
Lys Glu Trp Thr
Lys Met Glu Arg
Lys Met Arg Glu
Lys Met Val Trp
Lys Met Trp Val
Lys Arg Glu Met
Lys Arg Met Glu
Lys Thr Glu Trp
Lys Thr Trp Glu
Lys Val Met Trp
Lys Val Trp Met
Lys Trp Glu Thr
Lys Trp Met Val
Lys Trp Thr Glu
Lys Trp Val Met
Leu Phe Phe His
Leu Phe His Phe
Leu His Phe Phe
Met Ala Arg Trp
Met Ala Trp Arg
Met Glu Lys Arg
Met Glu Arg Lys
Met Lys Glu Arg
Met Lys Arg Glu
Met Lys Val Trp
Met Lys Trp Val
Met Asn Ile Trp
Met Arg Ala Trp
Met Arg Glu Lys
Met Arg Lys Glu
Met Arg Trp Ala
Met Val Lys Trp
Met Val Trp Lys
Met Trp Ala Arg
Met Trp Lys Val
Met Trp Arg Ala
Met Trp Val Lys
Asn His His Arg
Asn His Arg His
Asn Arg His His
Asn Trp Met Ile
Asn Trp Met Leu
Pro Gln Arg Tyr
Pro Gln Tyr Arg
Pro Arg Gln Tyr
Pro Arg Tyr Gln
Pro Tyr Gln Arg
Pro Tyr Arg Gln
Gln Met Val Trp
Gln Met Trp Val
Gln Pro Arg Tyr
Gln Pro Tyr Arg
Gln Arg Pro Tyr
Gln Arg Tyr Pro
Gln Val Met Trp
Gln Val Trp Met
Gln Trp Met Val
Gln Trp Val Met
Gln Tyr Pro Arg
Gln Tyr Arg Pro
Arg Ala Met Trp
Arg Ala Trp Met
Arg Cys Glu Arg
Arg Cys Arg Glu
Arg Cys Val Trp
Arg Cys Trp Val
Arg Glu Cys Arg
Arg Glu Lys Met
Arg Glu Met Lys
Arg Glu Arg Cys
Arg His His Asn
Arg His Asn His
Arg Lys Glu Met
Arg Lys Met Glu
Arg Met Ala Trp
Arg Met Glu Lys
Arg Met Lys Glu
Arg Met Trp Ala
Arg Asn His His
Arg Pro Gln Tyr
Arg Pro Tyr Gln
Arg Gln Pro Tyr
Arg Gln Tyr Pro
Arg Arg Cys Glu
Arg Arg Glu Cys
Arg Thr Thr Trp
Arg Thr Trp Thr
Arg Val Cys Trp
Arg Val Trp Cys
Arg Trp Ala Met
Arg Trp Cys Val
Arg Trp Met Ala
Arg Trp Thr Thr
Arg Trp Val Cys
Arg Tyr Pro Gln
Arg Tyr Gln Pro
Thr Glu Lys Trp
Thr Glu Trp Lys
Thr Lys Glu Trp
Thr Lys Trp Glu
Thr Arg Thr Trp
Thr Arg Trp Thr
Thr Thr Arg Trp
Thr Thr Trp Arg
Thr Trp Glu Lys
Thr Trp Lys Glu
Thr Trp Arg Thr
Thr Trp Thr Arg
Val Cys Arg Trp
Val Cys Trp Arg
Val Lys Met Trp
Val Lys Trp Met
Val Met Lys Trp
Val Met Gln Trp
Val Met Trp Lys
Val Met Trp Gln
Val Gln Met Trp
Val Gln Trp Met
Val Arg Cys Trp
Val Arg Trp Cys
Val Trp Cys Arg
Val Trp Lys Met
Val Trp Met Lys
Val Trp Met Gln
Val Trp Gln Met
Val Trp Arg Cys
Trp Ala Met Arg
Trp Ala Arg Met
Trp Cys Arg Val
Trp Cys Val Arg
Trp Glu Lys Thr
Trp Glu Thr Lys
Trp Ile Met Asn
Trp Ile Asn Met
Trp Lys Glu Thr
Trp Lys Met Val
Trp Lys Thr Glu
Trp Lys Val Met
Trp Leu Met Asn
Trp Leu Asn Met
Trp Met Ala Arg
Trp Met Ile Asn
Trp Met Lys Val
Trp Met Leu Asn
Trp Met Asn Ile
Trp Met Asn Leu
Trp Met Gln Val
Trp Met Arg Ala
Trp Met Val Lys
Trp Met Val Gln
Trp Asn Ile Met
Trp Asn Leu Met
Trp Asn Met Ile
Trp Asn Met Leu
Trp Gln Met Val
Trp Gln Val Met
Trp Arg Ala Met
Trp Arg Cys Val
Trp Arg Met Ala
Trp Arg Thr Thr
Trp Arg Val Cys
Trp Thr Glu Lys
Trp Thr Lys Glu
Trp Thr Arg Thr
Trp Thr Thr Arg
Trp Val Cys Arg
Trp Val Lys Met
Trp Val Met Lys
Trp Val Met Gln
Trp Val Gln Met
Trp Val Arg Cys
Tyr His Ile Met
Tyr His Leu Met
Tyr His Met Ile
Tyr His Met Leu
Tyr Ile His Met
Tyr Ile Met His
Tyr Leu His Met
Tyr Leu Met His
Tyr Met His Ile
Tyr Met His Leu
Tyr Met Ile His
Tyr Met Leu His
Tyr Pro Gln Arg
Tyr Pro Arg Gln
Tyr Gln Pro Arg
Tyr Gln Arg Pro
Tyr Arg Pro Gln
Tyr Arg Gln Pro
19-Hydroxycinnzeylanol 19-glucoside
Macrolactin O
3-O(alpha-L-rhamnopyranosyl)-3beta,5beta,14beta-trihydroxy-19-oxo-bufa-20,22-dienolide
3,6-BIS(DIETHYLAMINO)-2-(4-NITROPHENYL)SPIRO[ISOINDOLE-1,9-XANTHENE]-3-ONE
decanedioic acid,dimethyl benzene-1,4-dicarboxylate,2,2-dimethylpropane-1,3-diol,ethane-1,2-diol
(4-octylphenyl) 2-chloro-4-(4-heptylbenzoyl)oxybenzoate
POLY[TRIMETHYLOLPROPANE/DI(PROPYLENE GLYCOL)-ALT-ADIPIC ACID/PHTHALIC ANHYDRIDE], POLYOL
Tigilanol tiglate
A diterpenoid natural product isolated from the kernels of the Australian blushwood tree (Fontainea picrosperma). It is approved as a veterinary pharmaceutical for the treatment of non-metastatic and non-resectable canine mast cell tumours. C274 - Antineoplastic Agent > C177298 - Mitochondrial Targeting Antineoplastic Agent
3-[(21S,22S)-16-ethenyl-26-ethyl-4-hydroxy-12,17,21-trimethyl-11-propyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
caseanigrescen A
A diterpenoid of the clerodane group isolated from the leaves and flowers of Casearia nigrescens. It exhibits cytotoxicity against A2780 human ovarian cancer cell line.
sodium globostellatate A
An organic sodium salt that is the monosodium of globostellatic acid A. Isolated from the marine sponge Stelletta globostellata, it exhibits cytotoxicity against P-388 murine leukemia cells.
(+)-(2S,3S,4R)-10-de-O-carbamoyl-12-O-carbamoyl-Nbeta-acetylstreptothricin F acid
A natural product found in Streptomyces sp. I08A 1776.
(2S)-2-[[[4-[[[(2S)-1-[(2-methylpropan-2-yl)oxy]-1-oxo-3-phenylpropan-2-yl]amino]-oxomethyl]-1H-imidazol-5-yl]-oxomethyl]amino]-3-phenylpropanoic acid tert-butyl ester
3-cyclohexyl-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[3-(trifluoromethyl)phenyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-[3-(dimethylcarbamoyl)phenyl]phenyl]-N-ethyl-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-[3-[dimethylamino(oxo)methyl]phenyl]phenyl]-N-ethyl-3-(2-hydroxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-[4-[dimethylamino(oxo)methyl]phenyl]phenyl]-3-(2-hydroxyethyl)-N,N-dimethyl-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
N-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3,5-dimethyl-4-isoxazolesulfonamide
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3,5-dimethyl-4-isoxazolesulfonamide
(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-[4-[dimethylamino(oxo)methyl]phenyl]phenyl]-3-(2-hydroxyethyl)-N,N-dimethyl-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3beta,24S)-cholest-5-ene-3,24-diyl bis(hydrogen sulfate)
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
Protoporphyrin
A cyclic tetrapyrrole that consists of porphyrin bearing four methyl substituents at positions 3, 8, 13 and 17, two vinyl substituents at positions 7 and 12 and two 2-carboxyethyl substituents at positions 2 and 18. The parent of the class of protoporphyrins. D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents COVID info from COVID-19 Disease Map C1420 - Photosensitizing Agent D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Protoporphyrin IX is the final intermediate in the heme biosynthetic pathway. Protoporphyrin IX is the final intermediate in the heme biosynthetic pathway.
(1r,2r,13s,15s)-6,8-dihydroxy-13-methoxy-17,17-dimethyl-5,15-bis(3-methylbut-2-en-1-yl)-7-(2-methylbut-3-en-2-yl)-3,16-dioxapentacyclo[11.4.1.0²,¹¹.0²,¹⁵.0⁴,⁹]octadeca-4,6,8,11-tetraene-10,14-dione
5,10,17-trihydroxy-16-{1-[5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl}-11,15-dimethyl-3,8-dioxahexacyclo[10.7.0.0²,⁴.0⁵,¹¹.0⁷,⁹.0¹⁵,¹⁹]nonadecan-14-yl acetate
(3s,5r)-2-[(1s,2s,3s,4r,6r)-2,4-dihydroxy-4-methyl-3,6-bis({[(2z)-2-methylbut-2-enoyl]oxy})-5-oxocyclohexyl]-5-hydroxy-6-methylhepta-1,6-dien-3-yl (2z)-2-methylbut-2-enoate
4-{8,13,24,25-tetrahydroxy-1-methoxy-5,9,23-trimethyl-2,20,22-trioxahexacyclo[19.3.1.0³,¹⁹.0⁵,¹⁷.0⁶,¹⁴.0⁹,¹³]pentacos-17-en-10-yl}-5h-furan-2-one
[(1s,3ar,3br,5r,5ar,9ar,9bs,11ar)-1-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-1-hydroxyethyl]-1,3a,5,5a-tetrahydroxy-9a-methyl-9-oxo-2h,3h,3bh,4h,5h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-11a-yl]methyl acetate
(4s,5s)-2-{[(2r,3r,4s,5r,6r)-3-{[(3s)-6-amino-1-hydroxy-3-[(1-hydroxyethylidene)amino]hexylidene]amino}-4,5-dihydroxy-6-[(c-hydroxycarbonimidoyloxy)methyl]oxan-2-yl]amino}-5-[(1r)-2-amino-1-hydroxyethyl]-4,5-dihydro-3h-imidazole-4-carboxylic acid
3,9,12-tris(acetyloxy)-14-hydroxy-7,11,15,15,16,16-hexamethyl-10-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1,7-dien-6-yl acetate
{1-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)-1-hydroxyethyl]-1,3a,5,5a-tetrahydroxy-9a-methyl-9-oxo-2h,3h,3bh,4h,5h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-11a-yl}methyl acetate
5-[(1r,3as,3br,7s,9ar,9bs,11s,11as)-3a,11-dihydroxy-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]pyran-2-one
5-(3a,11-dihydroxy-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl)pyran-2-one
(1r,3r,5s,7r,9r,10s,12r,14s,15s,16s,18r,19r,22s,23r)-10,16,22-trihydroxy-9-methoxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-17-one
(1s,3ar,5s,6r,7s,7ar)-1-[(1r)-1-(acetyloxy)ethyl]-6-[(2-methylbutanoyl)oxy]-4-methylidene-7-[(2s)-2-methyloxiran-2-yl]-2-oxo-hexahydro-1h-inden-5-yl (2e)-4-(acetyloxy)-3-methylpent-2-enoate
(1r,3as,3br,5as,7s,9as,9bs,11ar)-3a,5a-dihydroxy-11a-methyl-1-(6-oxopyran-3-yl)-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde
5-[(1r,3ar,3bs,7s,9ar,9bs,11r,11as)-3a,3b,11-trihydroxy-9a,11a-dimethyl-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1h,2h,3h,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]pyran-2-one
(1r,3r,5s,7s,8s,9r,10r,13s)-7,9,10,13-tetrakis(acetyloxy)-8,12,15,15-tetramethyl-4-methylidenetricyclo[9.3.1.0³,⁸]pentadec-11-en-5-yl acetate
(1s,2s,4s,5r,7s,9r,10r,11s,12s,14s,15s,16r,17s,19s)-5,10,17-trihydroxy-16-[(1s)-1-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-11,15-dimethyl-3,8-dioxahexacyclo[10.7.0.0²,⁴.0⁵,¹¹.0⁷,⁹.0¹⁵,¹⁹]nonadecan-14-yl acetate
2-{[8a-methyl-4-methylidene-6-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-octahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
n-{2,6-dimethyl-7-[(2-methylbutanoyl)oxy]-8-(4-methylhexyl)-4,9-dioxo-1,5-dioxonan-3-yl}-2-hydroxy-3-[(hydroxymethylidene)amino]benzenecarboximidic acid
1-acetyl-2-hydroxy-3a,6,6,9b,11a-pentamethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthrene-7,10-dione
(1e,3s,4s,6s,9r,11s,12s,14s)-3,9,12-tris(acetyloxy)-14-hydroxy-7,11,15,15,16,16-hexamethyl-10-oxotricyclo[9.3.1.1⁴,⁸]hexadeca-1,7-dien-6-yl acetate
1-(acetyloxy)-11-[(acetyloxy)methyl]-3,6,6,15-tetramethyl-2-oxotricyclo[11.3.0.0⁵,⁷]hexadeca-3,11-dien-14-yl 3-phenylprop-2-enoate
(1s,3r,5r,6as,7r,8s,9r,10r,10ar)-1,3,9-tris(acetyloxy)-10-hydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl butanoate
(1s,2s,13r,15r)-6,8-dihydroxy-13-methoxy-17,17-dimethyl-5,15-bis(3-methylbut-2-en-1-yl)-7-(2-methylbut-3-en-2-yl)-3,16-dioxapentacyclo[11.4.1.0²,¹¹.0²,¹⁵.0⁴,⁹]octadeca-4,6,8,11-tetraene-10,14-dione
(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1,3,10-tris(acetyloxy)-5-hydroxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl butanoate
1,3(15),6-farnesatriene-10,11-diol; 10-o-[beta-d-glucopyranosyl(1→4)-beta-d-glucopyranoside]
{"Ingredient_id": "HBIN001000","Ingredient_name": "1,3(15),6-farnesatriene-10,11-diol; 10-o-[beta-d-glucopyranosyl(1\u21924)-beta-d-glucopyranoside]","Alias": "NA","Ingredient_formula": "C27H46O12","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9572","PubChem_id": "NA","DrugBank_id": "NA"}
atractyloside d
{"Ingredient_id": "HBIN017304","Ingredient_name": "atractyloside d","Alias": "NA","Ingredient_formula": "C27H46O12","Ingredient_Smile": "CC12CCC(CC1C(=C)CC(C2)OC3C(C(C(C(O3)CO)O)O)O)C(C)(C)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "562.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14421","TCMID_id": "1977","TCMSP_id": "NA","TCM_ID_id": "6490","PubChem_id": "101831402","DrugBank_id": "NA"}